Found 24 Enz. Inhib. hit(s) with all data for entry = 50011141 TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 810nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 813nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 1.55E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
3D Structure (crystal)TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 4.40E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 4.40E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 4.50E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 4.50E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 4.50E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 4.57E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 1.55E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 1.55E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 1.60E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 1.62E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 9.55E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 9.65E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 9.65E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 9.65E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: 9.70E+4nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
TargetKynurenine/alpha-aminoadipate aminotransferase, mitochondrial(Homo sapiens (Human))
Orion Pharma
Curated by ChEMBL
Orion Pharma
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Reversible inhibition of recombinant human KAT2 assessed as reduction in kynurenic acid formation using L-kynurenine as substrate by fluorescence ass...More data for this Ligand-Target Pair
